In this Korean-language episode of Lung Cancer Considered, Dr. Chul Kim is joined by Dr. Hye-Ryun Kim and Dr. Young Kwang Chae to discuss the evolving role of immunotherapy across the lung cancer treatment continuum. They explore perioperative strategies for resectable NSCLC, treatment selection and biomarkers in advanced disease, emerging research, and what they are looking forward to at WCLC 2026 in Seoul.

Guest Host:

Chul Kim, MD, MPH Thoracic Medical Oncologist and Associate Professor Georgetown University

Guests: Hye Ryun Kim, MD, PhD Medical Oncologist Chief of Lung Cancer Center Yonsei Cancer Center

Young Kwang Chae, MD, MPH, MBA Professor, Division of Hematology Oncology, Department of Medicine Northwestern University Feinberg School of Medicine

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör IASLC. Innehållet i podden är skapat av IASLC och inte av, eller tillsammans med, Poddtoppen.